Roving Reporter Asks: What Was the Biggest Development in CGT of 2025? - Summary - MDSpire
Feature

Roving Reporter Asks: What Was the Biggest Development in CGT of 2025?

IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to uncover the year’s defining breakthroughs

  • April 22, 2026

  • 1 min

Share

This episode of the Roving Reporter series, created in collaboration with IBTV, features insight from cell and gene therapy experts at the Meeting on the Mesa event. The discussions highlight key advancements in 2025 and underscore their implications for the industry's future. The content serves as a critical overview of current trends and provides valuable perspectives necessary for professionals aiming to stay informed in this rapidly evolving field.

Original Source(s)

Roving Reporter Asks: What Was the Biggest Development in CGT of 2025?

  • April 22, 2026

Related Content

Lung Cancer’s Hidden Layers

Study shows that tumor complexity can limit biopsy-based diagnosis

  • April 22, 2026

  • 2 min
High-Risk Smoldering Multiple Myeloma: BCMA-Directed CAR T-Cell Therapy Shows Activity

A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel led to a 100% measurable residual disease (MRD)-negativity rate in patients with high-risk smoldering ...

Baptist Health Heart & Vascular Care Expands Interventional Radiology Program with Nine Physicians

 Baptist Health Heart & Vascular Care announces the addition of nine highly skilled interventional radiology physicians to Baptist Health Miami Cardiac & Vascular Institute, part of Baptist Health Heart & Vascular Care, further strengthening its commitment to advanced, minimally invasive care.

  • by

  • April 21, 2026

  • 3 min